2005, Number 1
<< Back Next >>
Rev Fac Med UNAM 2005; 48 (1)
Sepsis. Up to date concepts
Carrillo ER, Carvajal RR
Language: Spanish
References: 50
Page: 24-29
PDF size: 55.70 Kb.
Text Extraction
No abstract
REFERENCES
Appelgren P, Hellstrom I, Wetzberg E et al. Risk Factors For Nosocomial Intensive Care Infection: A Long-Term Prospective Analysis. Acta Anaesthesiol Scand 2001; 45: 710-719.
Reinhart K, Bayer O, Brunkhorst F, Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002; 30: S302-S312.
Boldt J, Muller M, Kuhn D et al. Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Med 1996; 22:122-128.
Fourrier F, Chopin C, Goudemand J et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101: 816-823.
Pettila V, Hynninen M, Takkunen O et al. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002; 28: 1220-1225.
Panacek EA, Kaul M. IL-6 as a marker of excessive TNF-a activity in sepsis. Sepsis 1999; 3: 65-73.
Povoa P, Almeida E, Moreira P et al. C-reactived protein as an indicator of sepsis. Intensive Care Med 1998; 24: 1052-1056.
Ugarte H, Silva E, Mercan D et al. Procalcitonin usage as a marker of infectious in the ICU. Crit Care Med 1999; 27: 498-504.
Weinstein MP, Reller LP, Murphy JR et al. The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5: 35-53.
McCabe WR, Jackson GG. Gram negative bacteremia. Arch Intern Med 1962; 110: 92-100.
Kreger BE, Craven DE, McCabe WR. Gram negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68: 344-355.
Leibovici L, Shraga I, Drucker M et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379-386.
Niederman MS, Fein AM. The Adults Respiratory Distress Syndrome, And Nosocomial Pneumonia: A Common Clinical Sequence. Clin Chest Med 1990; 11: 633-656.
Brismar B, Malmborg AS et al. Piperacilin-Tazobactam versus Imipenem-Cilastatin for treatment of Intra-Abdominal Infections. Antimicrobial Agents and Chemotherapy 1997; 36: 2766-2733.
Kollef M, Niederman M. Antimicrobial resistance in the ICU: The time for action is now. Crit Care Med 2001; 29: N63.
Niederman MS. Appropriate use of antimicrobial agents: Challenges and strategies for improvement. Crit Care Med 2003; 31: 608-616.
Leone M, Bourgoin A, Cambon S et al. Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome. Crit Care Med 2003; 31: 462-467.
Kollef MH. Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med 2001; 29: N135-N142.
Paterson DL. Restrictive antibiotic policies are appropriate in intensive care units. Crit Care Med 2003; 31: S25-S28.
Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 2001; 29: N114-N120.
Wey SB, Mori M et al. Risk factors for hospital-acquired candidemia: A matched case-control study. Arch Intern Med 1989; 149: 2349-2353.
Jimenez MF, Marshall JC. Source control in the management of sepsis. Intensive Care Med 2001; 27: S49-S62.
Moss RL, Musemeche CA, Kosloske AM. Necrotizing fascitis in children: Prompt recognition and aggressive therapy improve survival. J Pediatr Surg 1996; 31: 1142-1146.
Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
Hollenberg SM, Ahrens TS, Astiz ME et al. Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 1999; 27: 639-660.
LeDoux D, Astiz ME, Carpati CM et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28: 2729-2732.
Martin C, Viviand X, Leone M et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28: 2758-2765.
Choi PTL, Yip G, Quinonez LG et al. Crystalloids vs colloids in fluid resuscitation: A systematic review. Crit Care Med 1999; 27: 200-210.
Cook D, Guyatt G. Colloid use for flui resuscitation: Evidence and spin. Ann Intern Med 2001; 135: 205-208.
Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systematic review of randomized trials. BMJ 1998; 316: 961-964.
De Backer D, Creteur J, Silva E et al. Effects of dopamine, norepinephrine, and epinephrine on the splachnic circulation in septic shock: Which is best? Crit Care Med 2003; 31: 1659-1667.
Holmes CL, Patel BM, Russell JA et al. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989-1002.
Carrillo ER, Carvajal RR, Hernández AC. Vasopresina: una nueva alternativa terapéutica en el enfermo grave. Rev Asoc Mex Med Crit Int 2003; 5: 162-171.
Bellomo R, Chapman M, Finfer S et al. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomized trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356: 2139-2143.
Kellum J, Deckler J. Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 2001; 29: 1526-1531.
Hébert PC, Wells G, Blajchman MA et al. A multicenter, randomized, controlled clinical trial of transfusion in critical care. N Engl J Med 1999; 340: 409-417.
Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269: 3024-3029.
Lorente JA, Landín L, De Pablo R et al. Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med 1003; 21: 1312-1318.
Brochard L, Roudat-Thoraval F, Roupie E et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trial Group on Tidal Volume Reduction in ARDS. Am J Respir Crit Care Med 1998; 158: 1831-1838.
Brower RG, Shanholtz CB, Fessler HE et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999; 27: 1492-1498.
Brower RG, Fessler HE. Mechanical ventilation in acute lung injury and acute respiratory distress syndrome. Clin Chest Med 2000; 21: 491-510.
Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
Annane D, Sebille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871.
Briegel J, Forst H, Haller M et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27: 723-732.
Kanji S, Devlin J, Piekos K, Racin E. Recombinant human activated protein C, drotrecogin alfa (activated): A novel therapy for severe sepsis. Pharmacotherapy 2001; 21: 1389-1402.
Vincent JL, Angus DC, Artigas A, Kalil A et al. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 2003; 31: 834-840.
Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-151.
Laterre PF, Wittebole X. Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification. Critical Care 2003; 7: 445-450.
Bernard GR, Vincent JL, Laterre PF, LaRosa SP et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
Dellinger RP, Carlet JM, Masur H, Gerlach H et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858-872.
Full text